Literature DB >> 20965993

Impact of early statin therapy on development of atrial fibrillation at the acute stage of myocardial infarction: data from the FAST-MI register.

Nicolas Danchin1, Laurent Fauchier, Eloi Marijon, Claude Barnay, Alain Furber, Philippe Mabo, Paul Bernard, Jean-Jacques Blanc, Xavier Jouven, Jean-Yves Le Heuzey, Bernard Charbonnier, Jean Ferrières, Tabassome Simon.   

Abstract

BACKGROUND: Atrial fibrillation developing at the acute stage of myocardial infarction is associated with untoward clinical outcomes. The aim of this study was to determine correlations between early statin therapy and atrial fibrillation in acute myocardial infarction.
METHODS: Patients (3396) with sinus rhythm developing acute myocardial infarction were enrolled in the French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction (FAST-MI).
RESULTS: Atrial fibrillation developed in 7.0% of patients without and 3.9% of patients with early (≤48 h of admission) statin therapy (p<0.001). Multivariable analysis, including the propensity score for early statin treatment, showed that statin therapy was associated with reduced risk of atrial fibrillation (OR 0.64; 95% CI 0.45 to 0.92, p=0.017). Compared to patients without early statin therapy, the OR for atrial fibrillation were 0.72 (0.49 to 1.04, p=0.080), 0.52 (0.28 to 0.95, p=0.034) and 0.40 (0.18 to 0.92, p=0.030) in patients on conventional, intermediate and high doses respectively.
CONCLUSIONS: This study is the first to document a correlation between early statin therapy and atrial fibrillation at the early stage of acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20965993     DOI: 10.1136/hrt.2010.201574

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  7 in total

Review 1.  Mortality Risk Associated with AF in Myocardial Infarction Patients.

Authors:  Rajiv Sankaranarayanan
Journal:  J Atr Fibrillation       Date:  2012-10-06

Review 2.  Mechanisms of new-onset atrial fibrillation complicating acute coronary syndrome.

Authors:  J Wang; Y-M Yang; J Zhu
Journal:  Herz       Date:  2014-10-30       Impact factor: 1.443

3.  Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score.

Authors:  Keith A A Fox; Gordon Fitzgerald; Etienne Puymirat; Wei Huang; Kathryn Carruthers; Tabassome Simon; Pierre Coste; Jacques Monsegu; Philippe Gabriel Steg; Nicolas Danchin; Fred Anderson
Journal:  BMJ Open       Date:  2014-02-21       Impact factor: 2.692

4.  New-Onset Atrial Fibrillation in St-Segment Elevation Myocardial Infarction: Predictors and Impact on Therapy And Mortality.

Authors:  Kisa Hyde Congo; Adriana Belo; João Carvalho; David Neves; Rui Guerreiro; João António Pais; Diogo Brás; Mafalda Carrington; Bruno Piçarra; Ana Rita Santos; José Aguiar
Journal:  Arq Bras Cardiol       Date:  2019-11       Impact factor: 2.000

Review 5.  Targeting inflammation and oxidative stress in atrial fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with statins.

Authors:  Ana Catarina Pinho-Gomes; Svetlana Reilly; Ralf P Brandes; Barbara Casadei
Journal:  Antioxid Redox Signal       Date:  2013-10-19       Impact factor: 8.401

Review 6.  Atrial fibrillation in acute ST-elevation myocardial infarction: clinical and prognostic features.

Authors:  Bulent Gorenek; Gulmira Kudaiberdieva
Journal:  Curr Cardiol Rev       Date:  2012-11

7.  Statins therapy can reduce the risk of atrial fibrillation in patients with acute coronary syndrome: a meta-analysis.

Authors:  Xue Zhou; Jian-lin Du; Jia Yuan; Yun-qing Chen
Journal:  Int J Med Sci       Date:  2013-01-10       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.